scispace - formally typeset
M

Marike L. D. Broekman

Researcher at Leiden University Medical Center

Publications -  202
Citations -  11272

Marike L. D. Broekman is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 32, co-authored 165 publications receiving 6384 citations. Previous affiliations of Marike L. D. Broekman include Brigham and Women's Hospital & Leiden University.

Papers
More filters
Journal ArticleDOI

Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, +417 more
TL;DR: The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points.
Journal ArticleDOI

Multidimensional communication in the microenvirons of glioblastoma.

TL;DR: The ways in which glioblastomas manipulate brain cells and immune cells in their environment to support tumour growth and the opportunities available for new therapies that disrupt these interactions are examined.
Journal ArticleDOI

Machine Learning and Neurosurgical Outcome Prediction: A Systematic Review

TL;DR: Based on the specific prediction task evaluated and the type of input features included, ML models predicted outcomes after neurosurgery with a median accuracy and area under the receiver operating curve of 94.5% and 0.83, respectively.
Journal ArticleDOI

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics.

TL;DR: This study investigated the possibilities, limitations and comparability of NTA, tRPS and hFC for analysis of tumor cell-derived EVs and synthetic mimics and detailed the differences in absolute quantification of EVs and liposomes using the three technologies.
Journal ArticleDOI

Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.

TL;DR: AAV8 proved to be more efficient than AAV1 or AAV2 vectors for gene delivery to all of the structures analyzed, including the cerebral cortex, hippocampus, olfactory bulb, and cerebellum, indicating that AAV8 is the superior serotype for gene Delivery to the CNS.